John L. Lamattina - May 28, 2021 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Director
Signature
/s/ Purnanand D. Sarma, Attorney-in-Fact
Stock symbol
IMNM
Transactions as of
May 28, 2021
Transactions value $
$0
Form type
4
Date filed
6/1/2021, 08:01 PM
Previous filing
May 26, 2021
Next filing
Jun 7, 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock Option (Right to Buy) Award $0 +3.75K $0.00 3.75K May 28, 2021 Common Stock 3.75K $20.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest 25% every quarter after the grant date.